Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $15.0 million.

  • Verastem's Change in Accured Expenses rose 20254.13% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 69723.88%. This contributed to the annual value of $8.0 million for FY2024, which is 17226.0% up from last year.
  • Latest data reveals that Verastem reported Change in Accured Expenses of $15.0 million as of Q3 2025, which was up 20254.13% from $4.0 million recorded in Q2 2025.
  • Verastem's 5-year Change in Accured Expenses high stood at $15.0 million for Q3 2025, and its period low was -$5.0 million during Q1 2021.
  • Over the past 5 years, Verastem's median Change in Accured Expenses value was $1.7 million (recorded in 2021), while the average stood at $1.9 million.
  • As far as peak fluctuations go, Verastem's Change in Accured Expenses plummeted by 30015.92% in 2021, and later skyrocketed by 228516.48% in 2025.
  • Over the past 5 years, Verastem's Change in Accured Expenses (Quarter) stood at $3.4 million in 2021, then crashed by 94.28% to $195000.0 in 2022, then plummeted by 635.9% to -$1.0 million in 2023, then surged by 460.48% to $3.8 million in 2024, then skyrocketed by 298.19% to $15.0 million in 2025.
  • Its last three reported values are $15.0 million in Q3 2025, $4.0 million for Q2 2025, and $2.7 million during Q1 2025.